These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28839954)

  • 21. Friend or Foe: MicroRNAs in the p53 network.
    Luo Z; Cui R; Tili E; Croce C
    Cancer Lett; 2018 Apr; 419():96-102. PubMed ID: 29330109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypothesis of "immunological testing" of partners--systems of "friend and foe" recognition in historical prospect].
    Markov AV; Kulikov AM
    Izv Akad Nauk Ser Biol; 2006; (4):389-403. PubMed ID: 17022471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?
    Andersen JB; Hassel BA
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):411-21. PubMed ID: 17097911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The consulting room computer--friend or foe?
    Donald J
    Practitioner; 1990 Jun; 234(1491):666-70. PubMed ID: 2217061
    [No Abstract]   [Full Text] [Related]  

  • 25. NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?
    Liu L; Li X
    Dig Dis Sci; 2017 Sep; 62(9):2211-2214. PubMed ID: 28631084
    [No Abstract]   [Full Text] [Related]  

  • 26. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX11: friend or foe in tumor prevention and carcinogenesis?
    Yang Z; Jiang S; Lu C; Ji T; Yang W; Li T; Lv J; Hu W; Yang Y; Jin Z
    Ther Adv Med Oncol; 2019; 11():1758835919853449. PubMed ID: 31210798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National health insurance--friend or foe?
    Broens B
    S Afr Med J; 2003 Oct; 93(10):725-6. PubMed ID: 14652950
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-infiltrating T cells--friend or foe of neoplastic cells?
    Parmiani G
    N Engl J Med; 2005 Dec; 353(25):2640-1. PubMed ID: 16371629
    [No Abstract]   [Full Text] [Related]  

  • 30. Dinucleoside polyphosphates-friend or foe?
    McLennan AG
    Pharmacol Ther; 2000; 87(2-3):73-89. PubMed ID: 11007992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial intelligence in radiology: friend or foe? Where are we now and where are we heading?
    Pakdemirli E
    Acta Radiol Open; 2019 Feb; 8(2):2058460119830222. PubMed ID: 30815280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARα regulates tumor progression, foe or friend?
    Gao J; Yuan S; Jin J; Shi J; Hou Y
    Eur J Pharmacol; 2015 Oct; 765():560-4. PubMed ID: 26409040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfur dioxide: foe or friend for life?
    Wang XB; Cui H; Liu X; Du JB
    Histol Histopathol; 2017 Dec; 32(12):1231-1238. PubMed ID: 28524210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The brain microenvironment: friend or foe for metastatic tumor cells?
    Winkler F
    Neuro Oncol; 2014 Dec; 16(12):1565-6. PubMed ID: 25395460
    [No Abstract]   [Full Text] [Related]  

  • 35. Serotonin in liver tumor: Friend or foe?
    Pang Q; Liu C; Zhang JY; Qu K; Song SD; Liu SS; Xu XS
    Hepatology; 2015 Jul; 62(1):319. PubMed ID: 25330322
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor-associated neutrophils: friend or foe?
    Fridlender ZG; Albelda SM
    Carcinogenesis; 2012 May; 33(5):949-55. PubMed ID: 22425643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy: cancer therapy's friend or foe?
    Grandér D; Panaretakis T
    Future Med Chem; 2010 Feb; 2(2):285-97. PubMed ID: 21426194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population change: friend or foe of the chronic care system?
    Wolf DA
    Health Aff (Millwood); 2001; 20(6):28-42. PubMed ID: 11816669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kras and Tumor Immunity: Friend or Foe?
    Cullis J; Das S; Bar-Sagi D
    Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29229670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of autophagy in hepatocellular carcinoma: friend or foe.
    Liu L; Liao JZ; He XX; Li PY
    Oncotarget; 2017 Aug; 8(34):57707-57722. PubMed ID: 28915706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.